Skip to Content

Onsenal Drug for Polyps Withdrawn from EU - EMA

The European Commission has withdrawn permission for the sale of Onsenal - used to treat intestinal polyps - in the EU, said the European Medicines Agency (EMA).

Pfizer, the manufacturer of the drug, could not prove its safety due to slow enrolment in an ongoing clinical trial. Doubts about its safety could not be dismissed, so Onsenal was banned.

Onsenal was marketed in all EU countries except for Bulgaria, Hungary, Malta, Romania and Slovenia.

Poll

Would you pay for CyprusNewsReport news stories?
Yes, I would pay for the news stories, I trust the site
8%
Yes, I would pay for certain news stories like oil-and-gas news
2%
Yes, I would pay for certain news stories like political news
2%
Yes, I would pay for certain news stories like economic news
1%
No, I would not pay for news stories
80%
Maybe, if the story was hot enough
8%
Total votes: 117